Photo taken from Diego Dibitetto/LinkedIn
May 27, 2024, 04:00
Diego Dibitetto: H2AX downregulation is a new mechanism of chemotherapy resistance in BRCA-deficient tumors
Diego Dibitetto, Postdoc fellow at the University of Bern, shared a post on LinkedIn:
“Our new paper is finally out!! H2AX downregulation is a new mechanism of chemotherapy resistance in BRCA-deficient tumors. Thanks to all the people involved Jos Jonkers, Alessandro Sartori, Josep Forment, Massimo Lopes, Claus Storgaard Sørensen, it was such a joy working with you!”